SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

MabVax Therapeutics Holdings Inc. (MBVX)

MBVX RSS Feed
Add MBVX Price Alert      Hide Sticky   Hide Intro
Moderator: follow_me
Search This Board:
Last Post: 9/16/2016 11:33:44 PM - Followers: 79 - Board type: Free - Posts Today: 0

www.mabvax.com

Ticker: MBVX
 

 

MabVax Therapeutics Holdings is a clinical-stage biopharmaceutical company focused on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. We generate our pipeline of antibody-based product candidates from patients who have been vaccinated with propriety vaccines licensed from Memorial Sloan-Kettering Cancer Center, or MSKCC. Our approach of surveying the protective immune response from many patients to identify the ideal monoclonal antibody candidate against a specific target on the surface of a cancer cell is a novel next-generation human antibody technology platform. Our approach to antibody discovery is to seek to identify the antibody candidates with superior performance characteristics while minimizing many of the toxicity and off target binding drawbacks of other discovery technologies. Our lead antibody candidates have been recovered from patients who had substantially better treatment outcomes than almost all other patients in clinical trials we conducted or that were conducted by our partners. Our therapeutic vaccines were developed at MSKCC and are exclusively licensed to us pursuant to agreements with MSKCC in 2008. These vaccines are administered in the adjuvant (period following conventional treatment consisting of watchful waiting) setting and have shown in clinical studies to elicit a protective antibody response. The antibodies are intended to seek out circulating tumor cells and micrometastases (small clusters of cancer cells) to kill them before they can cause cancer recurrence. Our lead cancer vaccines targeting recurrent sarcoma (soft tissue cancer) and ovarian cancer are currently in proof of concept Phase II multi-center clinical trials. Both trials have received substantial federal grant monies to support their development. A vaccine to address the orphan disease neuroblastoma (cancer starting in the adrenal gland of children which may spread to nervous tissue and bone marrow) has completed an initial Phase I trial at MSKCC and is expected be ready for a Phase II trial by early 2015. MSKCC and the Company have completed additional Phase I vaccine clinical trials in melanoma, ovarian cancer, and small cell lung cancer over the last three years.MBVX Intraday Stock Chart

1d 1m 3m 6m 1y 2y 5y
 
 
 
MBVX vs ETF alternatives
ETFs Today 3mths 1Yr YTD
<tr class="symRow selected" '="" nowrap=""> MBVX 2.65% 149.46% 61.90% 16.00%
IJR -0.75% 0.24% 9.06% 4.04%
EES -0.52% 1.71% 5.66% 2.96%
SCHA -0.62% 2.87% 10.13% 5.04%
VIOO -0.60% 0.58% 9.21% 3.77%
VB -0.59% 1.19% 9.77% 5.33%
DWAS -0.55% 1.83% 12.72% 6.64%
SAA -0.21% -49.24% -40.19% -47.12%
Most Recent MBVX Videos
No MBVX Videos…

My Stocks Activity For MBVX

Sassykoala avatar Sassykoala added MBVX
Added to MyStocks 48 days ago
kjb492272 avatar kjb492272 added MBVX
Added to MyStocks 72 days ago
RedDuc avatar RedDuc added MBVX
Added to MyStocks 93 days ago
kks11 avatar kks11 removed MBVX
Removed from MyStocks 107 days ago
kks11 avatar kks11 added MBVX
Added to MyStocks 143 days ago
More MBVX My Stocks Activity


 
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MBVX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#1132   In since before the split and uplist I ringao 09/16/16 11:33:44 PM
#1131   Got a Pumpy-McDumpy Email Promotion recently. Someone paid Homebrew 09/13/16 05:08:30 PM
#1130   Plan to go in big in the morning. follow_me 09/08/16 10:08:20 PM
#1129   I believe that MBVX is a great mid follow_me 09/08/16 10:07:33 PM
#1128   Will be watching closely after conference follow_me 09/08/16 10:06:41 PM
#1127   Wow just a 3.78 million shares left in float!! follow_me 09/08/16 10:06:01 PM
#1126   DMPI (Del Mar Pharma) will be the next kellyaemmerson 09/07/16 02:05:45 PM
#1125   Thx. Rogerthat1 09/07/16 12:16:34 PM
#1124   Sorry for your loss. 3DPrintInvestor 09/07/16 12:16:14 PM
#1123   Had a paid pump out this morning on Rogerthat1 09/07/16 12:15:11 PM
#1122   New Investor Presentation 3DPrintInvestor 09/06/16 05:35:00 PM
#1121   need to pps stated here, MabVax Therapeutics Holdings mick 08/29/16 03:45:31 PM
#1120   is this ah 3-d company ????? 'MabVax mick 08/29/16 03:44:09 PM
#1119   Nice hints in August 11 10-Q filing that 3DPrintInvestor 08/29/16 10:47:08 AM
#1118   Nice summary Lloyd. I hold a small position Rogerthat1 08/19/16 11:05:52 PM
#1117   Pretty good way to structure a RS if LloydDC 08/19/16 09:18:10 PM
#1116   Hmmm, I didn't realize you could do both 5TOP 08/18/16 03:58:02 PM
#1115   They did both. $4.80 ish. SQUINTZ76 08/18/16 03:54:04 PM
#1114   Sorry what was the opening price after r/s, 5TOP 08/18/16 03:41:59 PM
#1113   Did they perform thier R/S and uplisting simultaneously? 5TOP 08/18/16 03:41:01 PM
#1112   I love Nasdaq Rogerthat1 08/17/16 05:55:50 PM
#1111   MBVX moved to the Nasdaq from the OTC: Renee 08/17/16 05:04:02 PM
#1110   MBVX one for 7.4 reverse split: Renee 08/16/16 04:18:28 PM
#1109   Nice. This will spike IMO. Rogerthat1 08/13/16 06:03:02 PM
#1108   Market cap after split and Nasdaq up list LloydDC 08/13/16 11:02:30 AM
#1107   Great thx. It was late lol. Two preliminary Rogerthat1 08/13/16 10:59:44 AM
#1106   Total shares originally offered were 1,299,376 @$4.81 proceeds LloydDC 08/13/16 10:42:51 AM
#1105   Dang it they upped their offering seems like Rogerthat1 08/13/16 01:20:52 AM
#1104   From 10Q Clinical Product Development – Recent Updates Rogerthat1 08/11/16 08:23:02 PM
#1103   Great run last couple weeks. SQUINTZ76 08/11/16 03:59:09 PM
#1102   I think that uplisting to NASDAQ is pretty SanDiegoAlan 08/05/16 02:19:30 AM
#1101   The r/s without strong news and financials are Amatuer17 08/04/16 02:21:37 PM
#1100   In connection with the listing of our shares Rogerthat1 08/04/16 02:14:28 AM
#1099   Ouch Rogerthat1 07/28/16 06:44:36 PM
#1098   On free options..... Rymankoly 07/28/16 06:44:26 PM
#1097   Insiders loading up Rogerthat1 07/28/16 06:24:19 PM
#1096   whats next burp (besides a drink?) croptop 07/25/16 08:20:58 PM
#1095   Look at 10-k filed on 30th Jun - Amatuer17 07/05/16 08:02:55 PM
#1094   This didn't jump out at me in the ringao 07/05/16 07:24:51 PM
#1093   R/S approved by management with a view to Amatuer17 07/03/16 05:31:25 AM
#1092   Look at Novartis deal with XNCR -$2.4B Xnc is Amatuer17 07/01/16 06:01:34 AM
#1091   Any updates on the potential JUNO partnership ? WCT 06/10/16 04:03:45 PM
#1090   If you look at ASCO - there were Amatuer17 06/09/16 06:49:54 AM
#1089   MBVX CHART Nice move to test 50ma .655. bUrRpPPP! 06/09/16 05:23:09 AM
#1088   nice move, needs volume... croptop 06/08/16 01:24:27 PM
#1087   MBVX - Where's the bottom? jaytea 05/31/16 12:20:02 PM
#1086   IMO ego and greed....gets in the way when croptop 05/31/16 11:34:55 AM
#1085   My guess is he's gone the membership route jembers 05/29/16 09:54:01 PM
#1084   Comical that he sells a "membership." ShadowElite 05/29/16 01:53:35 AM
#1083   Yea, LOL, no problem, i he front loads croptop 05/27/16 07:51:00 PM
PostSubject